Date | Insider | Price | Amount |
---|---|---|---|
12-28-2023 Insider Buy |
Randal J. Kirk |
$1.41 CAGR » |
$136,327.26 96,686 shares |
9-22-2023 Insider Buy |
Dean J. Mitchell Director |
$1.41 CAGR » |
$35,250.00 25,000 shares |
8-16-2023 Insider Buy |
Randal J. Kirk |
$1.52 CAGR » |
$757,611.78 500,000 shares |
8-14-2023 Insider Buy |
Fred Hassan Director |
$1.75 CAGR » |
$998,103.75 570,345 shares |
1-27-2023 Insider Buy |
Harry Thomasian Jr. Chief Financial Officer |
$1.75 CAGR » |
$49,999.25 28,571 shares |
1-27-2023 Insider Buy |
Helen Sabzevari President and CEO |
$1.75 CAGR » |
$39,999.75 22,857 shares |
1-27-2023 Insider Buy |
Jeffrey Thomas Perez SVP, IP Affairs |
$1.75 CAGR » |
$49,999.25 28,571 shares |
1-27-2023 Insider Buy |
Rutul R. Shah Chief Operating Officer |
$1.75 CAGR » |
$15,998.50 9,142 shares |
8-23-2022 Insider Buy |
Harry Thomasian Jr. Chief Financial Officer |
$2.09 CAGR » |
$51,205.00 24,500 shares |
11-26-2021 Insider Buy |
Harry Thomasian Jr. Chief Financial Officer |
$3.80 CAGR » |
$100,831.00 26,500 shares |
11-23-2021 Insider Buy |
Randal J. Kirk Director and >10% Owner |
$3.63 CAGR » |
$3,634,787.41 1,000,000 shares |
10-7-2020 Insider Buy |
Trading S.A. Ares >10% Owner |
$3.70 CAGR » |
$24,999,997.44 6,758,400 shares |
8-12-2020 Insider Buy |
Randal J. Kirk Executive Chairman |
$4.42 CAGR » |
$5,346,020.16 1,209,384 shares |
3-20-2020 Insider Buy |
Randal J. Kirk Executive Chairman |
$2.24 CAGR » |
$2,241,625.12 1,000,000 shares |
1-31-2020 Insider Buy |
Randal J. Kirk Executive Chairman |
$5.86 CAGR » |
$34,999,998.56 5,972,696 shares |
Also See: Institutional Holders of PGEN
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 12/29/2023 | |
End date: | 04/26/2024 | |
Start price/share: | $1.34 | |
End price/share: | $1.41 | |
Dividends collected/share: | $0.00 | |
Total return: | 5.22% | |
Annualized Gain: | 16.16% | |
Starting investment: | $10,000.00 | |
Ending investment: | $10,522.00 | |
Years: | 0.32 |
Precigen Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Precigen insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PGEN
Free PGEN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Precigen Insider Buying occurred are:
Merrimack Pharmaceuticals Insider Buying |